Evidence map›Paper›PMID 35697842›Full record

ArticleNature medicine2022

Brain lesions disrupting addiction map to a common human brain circuit.

Juho Joutsa, Khaled Moussawi, Shan H Siddiqi, Amir Abdolahi, William Drew, Alexander L Cohen, Thomas J Ross, Harshawardhan U Deshpande, Henry Z Wang, Joel Bruss and 6 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 139 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 3 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06793488 early_phase1recruitingnot on this mapstarted 2025, after this paper: background citation

Neural Mechanisms of Anxiety During Early and Protracted Abstinence in Alcohol Use Disorder

TypeinterventionalSponsorColumbia UniversityRan2025 to 2029Enrolled60ConditionsAlcohol Use DisorderArmsDisulfiram 250 mg, functional MRI
NCT07210268 narecruitingnot on this mapstarted 2026, after this paper: background citation

Temporal Interference Methods for Addiction Treatment

TypeinterventionalSponsorIndiana UniversityRan2026 to 2027Enrolled120ConditionsNicotine Use Disorder, Substance Use DisordersArmsTI-NDBS, Sham TI-NDBS
3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 3 syntheses or guidelines pooled it, 194 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial.Movement disorders : official journal of the Movement Disorder Society · 2024
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Article
  13. Multi-modal lesion mapping of expressive aprosodia.Cortex; a journal devoted to the study of the nervous system and behavior · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Juho Joutsa *Turku Brain and Mind Center, Clinical Neurosciences, University of Turku, Turku, Finland. jtjout@utu.fi.ORCID http://orcid.org/0000-0002-3457-9415
Khaled Moussawi *National Institute on Drug Abuse-Intramural Research Program, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6378-0428
Shan H Siddiqi *Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Amir AbdolahiClinical Affairs, Philips Healthcare, Cambridge, MA, USA.
William DrewBerenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9178-8731
Alexander L CohenBerenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6557-5866
Thomas J RossNational Institute on Drug Abuse-Intramural Research Program, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-7745-3572
Harshawardhan U DeshpandeNational Institute on Drug Abuse-Intramural Research Program, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-8620-8280
Henry Z WangDepartment of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA.
Joel BrussDepartments of Pediatrics, Neurology & Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Elliot A SteinNational Institute on Drug Abuse-Intramural Research Program, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-0593-0269
Nora D VolkowIntramural Research Program, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-6668-0908
Jordan H GrafmanShirley Ryan AbilityLab, Chicago, IL, USA.
Edwin van WijngaardenDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.
Aaron D BoesDepartments of Pediatrics, Neurology & Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.ORCID http://orcid.org/0000-0002-7865-9257
Michael D FoxBerenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Boston, MA, USA. foxmdphd@gmail.com.ORCID http://orcid.org/0000-0001-8848-6399
Brigham and Women's Hospital · USNational Institute on Drug Abuse · USUniversity of Iowa Hospitals and Clinics · USUniversity of Rochester Medical Center · USBeth Israel Deaconess Medical Center · USNational Institute on Alcohol Abuse and Alcoholism · USNorthwestern University · USPhilips (United States) · US

Funding

Neurobiology of Substance Abuse and AddictionZIAAA000550 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI VOLKOW, NORA D. · 2009 to 2025
$115.1M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)P50HD103556 · NICHD · UNIVERSITY OF IOWA · PI Lane Strathearn · 2021 to 2026
$8.5M
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptomsR01MH113929 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2017 to 2026
$6.9M
Role of Myeloid Cells in Cerebrovascular Permeability and Reactivity in Older HIV Infected IndividualsR01AG054328 · NIA · UNIVERSITY OF ROCHESTER · PI MAGGIRWAR, SANJAY B., SCHIFITTO, GIOVANNI · 2017 to 2021
$3.5M
Predicting Cognitive Outcomes from Stroke Based on Lesion LocationR01NS114405 · NINDS · UNIVERSITY OF IOWA · PI BOES, AARON D · 2020 to 2024
$2.1M
Personalized circuit-based neuromodulation targets for depressionK23MH121657 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI SIDDIQI, SHAN · 2020 to 2024
$978k
TMS effects on circuit plasticity and drug seeking in mice - Diversity SupplementR00DA048085 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOUSSAWI, KHALED · 2021 to 2023
$930k
Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative diseaseR56AG069086 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI FOX, MICHAEL D · 2021 to 2021
$873k
The neuroanatomical basis for face processing deficits in autism spectrum disorderK23MH120510 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI COHEN, ALEXANDER LI · 2020 to 2023
$779k
Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulationR21MH126271 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI FOX, MICHAEL D · 2021 to 2022
$492k
Identifying neuromodulation targets for pain in the human brainR21NS123813 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI FOX, MICHAEL D · 2022 to 2023
$492k
NIA NIH HHS R01 AG054328NIA NIH HHS R56 AG069086NICHD NIH HHS P50 HD103556NICHD NIH HHS P50 HD105351NIDA NIH HHS K99 DA048085NIDA NIH HHS R00 DA048085NIMH NIH HHS K23 MH120510NIMH NIH HHS K23 MH121657NIMH NIH HHS L30 MH127717NIMH NIH HHS R01 MH113929NIMH NIH HHS R21 MH126271NINDS NIH HHS R01 NS114405NINDS NIH HHS R21 NS123813
6 · The paper itself

Abstract

Drug addiction is a public health crisis for which new treatments are urgently needed. In rare cases, regional brain damage can lead to addiction remission. These cases may be used to identify therapeutic targets for neuromodulation. We analyzed two cohorts of patients addicted to smoking at the time of focal brain damage (cohort 1 n = 67; cohort 2 n = 62). Lesion locations were mapped to a brain atlas and the brain network functionally connected to each lesion location was computed using human connectome data (n = 1,000). Associations with addiction remission were identified. Generalizability was assessed using an independent cohort of patients with focal brain damage and alcohol addiction risk scores (n = 186). Specificity was assessed through comparison to 37 other neuropsychological variables. Lesions disrupting smoking addiction occurred in many different brain locations but were characterized by a specific pattern of brain connectivity. This pattern involved positive connectivity to the dorsal cingulate, lateral prefrontal cortex, and insula and negative connectivity to the medial prefrontal and temporal cortex. This circuit was reproducible across independent lesion cohorts, associated with reduced alcohol addiction risk, and specific to addiction metrics. Hubs that best matched the connectivity profile for addiction remission were the paracingulate gyrus, left frontal operculum, and medial fronto-polar cortex. We conclude that brain lesions disrupting addiction map to a specific human brain circuit and that hubs in this circuit provide testable targets for therapeutic neuromodulation.

Indexed as

AlcoholismBrain InjuriesConnectomeBrainBrain MappingCohort StudiesHumansMagnetic Resonance Imaging

Identifiers

PMID35697842
PMCPMC9205767
OpenAlexW4282558403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.